Acute and long-term studies of the mechanisms of action of beta-blocking drugs in lowering blood pressure (Q35537965)

8 August 2017

1 reference

title

Acute and long-term studies of the mechanisms of action of beta-blocking drugs in lowering blood pressure (English)

1 reference

8 August 2017

K. O. Stumpe

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14499

8 October 2022

R. Kolloch

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14499

8 October 2022

H. Vetter

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14499

8 October 2022

W. Gramann

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14499

8 October 2022

F. Krück

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14499

8 October 2022

C. Ressel

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14499

8 October 2022

M. Higuchi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14499

8 October 2022

language of work or name

English

0 references

publication date

1 May 1976

1 reference

8 August 2017

31 May 1976

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14499

full work available at URL

8 October 2022

https://api.elsevier.com/content/article/PII:0002934376909050?httpAccept=text/xml

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1016/0002-9343(76)90905-0

https://api.elsevier.com/content/article/PII:0002934376909050?httpAccept=text/plain

15 October 2022

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1016/0002-9343(76)90905-0

American Journal of Medicine

15 October 2022

published in

1 reference

8 August 2017

1 reference

8 August 2017

1 reference

8 August 2017

page(s)

853-865

1 reference

USE OF PROPRANOLOL (INDERAL) IN TREATMENT OF HYPERTENSION.

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90905-0

Effects of beta-adrenergic blockade on the cardiac response to maximal and submaximal exercise in man

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90905-0

Effects of beta-adrenergic blockade during exercise in hypertensive and ischaemic heart-disease

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90905-0

Immediate hemodynamic effects of beta-adrenergic blockade with propranolol in normotensive and hypertensive man

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90905-0

The paradox of beta-adrenergic blockade in hypertension

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90905-0

Propranolol therapy in essential hypertension

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90905-0

Beta adrenergic blockade in hypertension. Practical and theoretical implications of long-term hemodynamic variations

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90905-0

The effects of some beta-adrenoreceptor blocking drugs on the uptake and release of noradrenaline by the heart

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90905-0

Effect of stellate ganglion stimulation on myocardial blood flow, oxygen consumption, and cardiac efficiency during beta-adrenoceptor blockade.

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90905-0

Central Hypotensive Activity of dl- and d-Propranolol

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90905-0

Mechanism of Beta-Blockade Hypotension

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90905-0

Effects of cyclic AMP, sympathomimetic amines, and adrenergic receptor antagonists on renin secretion.

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90905-0

Effect of alprenolol on blood pressure and plasma renin activity in hypertensive patients

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90905-0

Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90905-0

Beta-adrenergic blockade in essential hypertension. Effects of propranolol on hemodynamic parameters and plasma renin activity

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90905-0

Dissociation between renin and arterial pressure responses to beta-adrenergic blockade in human essential hypertension

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90905-0

Effect of practolol on blood pressure and renin release in man

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90905-0

Beta-blockers and plasma renin activity in hypertension.

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90905-0

Comparison of the effects on renin release of beta adrenergic antagonists with differing properties

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90905-0

Diurnal Variation of Plasma Aldosterone, Cortisol and Renin Activity in Supine Man

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90905-0

Effect of chronic beta-adrenergic blockade on blood pressure and release of renin, aldosterone and cortisol in essential hypertension (author's transl)

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90905-0

A potent beta-adrenoreceptor blocking drug: 4-(2-hydroxy-3-isopropylaminopropoxy)indole

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90905-0

Comparative chronotropic activity of beta-adrenoceptive antagonists

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90905-0

Role of the pressor action of angiotensin II in experimental hypertension.

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90905-0

Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90905-0

Radioimmunoassay for aldosterone without chromatography. 2. Determination of plasma aldosterone

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90905-0

The effect of chronic adrenergic receptor blockade on plasma renin activity in man

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90905-0

Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90905-0

The effects of alteration of blood-volume on the concentration of circulating angiotensin in anaesthetized dogs

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90905-0

Role of the sympathetic nervous system in regulating renin and aldosterone production in man.

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90905-0

Adrenergic receptor mediation of renin secretion.

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90905-0

Sympathetic innervation of the juxtaglomerular cells of the kidney

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90905-0

Adrenergic Receptor Mechanisms and Renin Secretion**

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90905-0

Antihypertensive action of propranolol. Specific antirenin responses in high and normal renin forms of essential, renal, renovascular and malignant hypertension.

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90905-0

Renin and sympathetic nervous system responsiveness to adrenergic stimuli in essential hypertension

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90905-0

Cardiovascular effects of angiotensin mediated by the central nervous system

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90905-0

Tilt test for investigating a neural component in hypertension. Its correlation with clinical characteristics

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90905-0

A hemodynamic comparison of essential and renovascular hypertension. Cardiac output and total peripheral resistance: supine and tilted patients.

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90905-0

Cardiovascular responses to carotid and vertebral artery infusions of propranolol

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90905-0

Clinical pharmacology of propranolol

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90905-0

Comparative studies on central factors contributing to the hypotensive action of propranolol, alprenolol, and their enantiomers

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90905-0

Hemodynamic and hypotensive effects of long-term therapy with chlorothiazide

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90905-0

Hemodynamic changes in long-term diuretic therapy of essential hypertension. A comparative study of chlorthalidone, polythiazide and hydrochlorothiazide

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90905-0

Mechanism of Increased Sodium Reabsorption during Propranolol Administration

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90905-0

Abnormal renal haemodynamics and renin suppression in hypertensive patients

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90905-0

Abnormally sustained aldosterone secretion during salt loading in patients with various forms of benign hypertension; relation to plasma renin activity

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90905-0

The control of aldosterone secretion in normal and hypertensive man: abnormal renin-aldosterone patterns in low renin hypertension

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90905-0

Plasma aldosterone-renin interrelationships in various forms of essential hypertension. Studies using a rapid assay of plasma aldosterone

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90905-0

Low renin, "normal" aldosterone and hypertension: circadian rhythm of renin, aldosterone, cortisol and growth hormone

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90905-0

Potassium balance and the control of renin secretion

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90905-0

The influence of potassium administration and of potassium deprivation on plasma renin in normal and hypertensive subjects

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90905-0

Neurogenic factors in human hypertension: mechanism or myth?

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90905-0

ALDOSTERONE SECRETION AND VARIOUS FORMS OF HYPERTENSIVE VASCULAR DISEASE

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90905-0

β-Adrenergic Blockade in Diuretic-Treated Patients with Essential Hypertension

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90905-0

Treatment of essential hypertension with combined vasodilation and beta-adrenergic blockade

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90905-0

15 October 2022

Identifiers

DOI

1 reference

8 August 2017

1 reference